BG101787A - Aprotinine options having improved properties - Google Patents

Aprotinine options having improved properties

Info

Publication number
BG101787A
BG101787A BG101787A BG10178797A BG101787A BG 101787 A BG101787 A BG 101787A BG 101787 A BG101787 A BG 101787A BG 10178797 A BG10178797 A BG 10178797A BG 101787 A BG101787 A BG 101787A
Authority
BG
Bulgaria
Prior art keywords
aprotinine
options
improved properties
improvedenzymoinhibiting
andto
Prior art date
Application number
BG101787A
Other languages
Bulgarian (bg)
English (en)
Inventor
Werner Schroeder
Soren Bjorn
Kjeld Norris
Viggo DINNES
Niels CHRISTENSEN
Leif Norkskov-Lauritsen
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of BG101787A publication Critical patent/BG101787A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114Kunitz type inhibitors
    • C07K14/8117Bovine/basic pancreatic trypsin inhibitor (BPTI, aprotinin)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114Kunitz type inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
BG101787A 1996-07-25 1997-07-22 Aprotinine options having improved properties BG101787A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19629982A DE19629982A1 (de) 1996-07-25 1996-07-25 Aprotinin-Varianten mit verbesserten Eigenschaften

Publications (1)

Publication Number Publication Date
BG101787A true BG101787A (en) 1998-10-30

Family

ID=7800774

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101787A BG101787A (en) 1996-07-25 1997-07-22 Aprotinine options having improved properties

Country Status (37)

Country Link
US (2) US6482798B2 (xx)
EP (1) EP0821007B1 (xx)
JP (1) JPH10101700A (xx)
KR (1) KR980009283A (xx)
CN (1) CN1172116A (xx)
AR (1) AR008783A1 (xx)
AT (1) ATE260975T1 (xx)
AU (2) AU2870197A (xx)
BG (1) BG101787A (xx)
BR (1) BR9704068A (xx)
CA (1) CA2207071A1 (xx)
CO (1) CO4890857A1 (xx)
CZ (1) CZ236797A3 (xx)
DE (2) DE19629982A1 (xx)
DZ (1) DZ2276A1 (xx)
EE (1) EE9700177A (xx)
ES (1) ES2217350T3 (xx)
HN (1) HN1997000094A (xx)
HR (1) HRP970384A2 (xx)
HU (1) HUP9701290A3 (xx)
ID (1) ID17508A (xx)
IL (1) IL121361A0 (xx)
MA (1) MA24279A1 (xx)
NO (1) NO973426L (xx)
NZ (1) NZ328402A (xx)
PE (1) PE92298A1 (xx)
PL (1) PL321341A1 (xx)
RU (1) RU2197983C2 (xx)
SG (1) SG71714A1 (xx)
SK (1) SK101997A3 (xx)
SV (1) SV1997000068A (xx)
TN (1) TNSN97130A1 (xx)
TR (1) TR199700688A2 (xx)
TW (1) TW480271B (xx)
UA (1) UA55380C2 (xx)
YU (1) YU31697A (xx)
ZA (1) ZA976585B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19725014A1 (de) * 1997-06-13 1998-12-17 Bayer Ag Aprotininvarianten mit verbesserten Eigenschaften und Bikunine von Aprotininvarianten
US6974188B2 (en) * 2003-08-13 2005-12-13 Cosco Management, Inc. Chair with pivotable chair back
WO2006042327A2 (en) * 2004-10-12 2006-04-20 Large Scale Biology Corporation Plant-produced recombinant aprotinin and aprotinin variants
US20060218667A1 (en) * 2004-10-12 2006-09-28 Vojdani Fakhrieh S Plant-produced recombinant aprotinin and aprotinin variants
EP2360258B1 (en) * 2005-02-18 2014-10-08 Angiochem Inc. Aprotinin polypeptides for transporting a compound across the blood-brain barrier
WO2008077478A1 (en) * 2006-12-22 2008-07-03 Bayer Schering Pharma Aktiengesellschaft Preparation and use of variants of the kunitz domain 2 of the human placental bikunin gene
WO2008110301A1 (de) * 2007-03-13 2008-09-18 Bayer Schering Pharma Aktiengesellschaft Aprotinin-varianten mit verbesserten eigenschaften
DE102007056231A1 (de) 2007-09-08 2009-03-12 Bayer Healthcare Ag Herstellung und Verwendung von Varianten humander Kunitz-Typ Protease-Inhibitoren (hKTPI)
BRPI1103921A2 (pt) 2011-08-17 2013-08-06 Mahle Metal Leve Sa camisa de cilindro e liga de ferro fundido

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU560584B2 (en) * 1983-07-28 1987-04-09 Bayer Aktiengesellschaft Homologues of aprotinin
US4595974A (en) * 1984-09-10 1986-06-17 Burroughs Corporation Base drive circuit for a switching power transistor
GB2208511A (en) 1987-08-07 1989-04-05 Bayer Ag Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology
US5591603A (en) 1987-08-28 1997-01-07 Novo Nordisk A/S Process for preparing aprotinin and aprotinin analogs in yeast cells
DK225488D0 (da) * 1988-04-26 1988-04-26 Novo Industri As Polypeptid
DK463887D0 (da) 1987-09-07 1987-09-07 Novo Industri As Gaerleader
DK105489D0 (da) 1989-03-03 1989-03-03 Novo Nordisk As Polypeptid
US5231010A (en) 1989-09-13 1993-07-27 Bayer Aktiengesellschaft Recombinant aprotinin variants genetically engineered process for the microbial preparation of homogeneously processed aprotinin variants and the therapeutic use thereof
DE3930522A1 (de) * 1989-09-13 1991-03-21 Bayer Ag Rekombinante aprotinin-varianten - gentechnisches verfahren zur mikrobiellen herstellung von homogen prozessierten aprotinin-varianten sowie die therapeutische anwendung derselben
IL99585A0 (en) * 1990-10-01 1992-08-18 Novo Nordisk As Aprotinin analogues,their production and pharmaceutical compositions containing them
US5747449A (en) * 1992-07-13 1998-05-05 Corvas International, Inc. Bovine pancreatic trypsin inhibitor derived inhibitors of factor XA
KR100199565B1 (ko) * 1994-08-19 1999-06-15 차동천 승화형 감열전사 기록용 수용지의 중간층 제조방법

Also Published As

Publication number Publication date
ID17508A (id) 1998-01-08
DE19629982A1 (de) 1998-01-29
IL121361A0 (en) 1998-01-04
NO973426D0 (no) 1997-07-24
ES2217350T3 (es) 2004-11-01
AR008783A1 (es) 2000-02-23
CA2207071A1 (en) 1998-01-25
TR199700688A2 (xx) 1998-02-21
RU2197983C2 (ru) 2003-02-10
SV1997000068A (es) 1998-07-09
CO4890857A1 (es) 2000-02-28
JPH10101700A (ja) 1998-04-21
HUP9701290A3 (en) 2000-08-28
AU2870197A (en) 1998-02-05
PL321341A1 (en) 1998-02-02
DE59711356D1 (de) 2004-04-08
AU762041B2 (en) 2003-06-19
SK101997A3 (en) 1998-03-04
TW480271B (en) 2002-03-21
US20030096752A1 (en) 2003-05-22
YU31697A (sh) 1999-07-28
HUP9701290A2 (hu) 1999-06-28
EP0821007A2 (de) 1998-01-28
MX9705605A (es) 1998-08-30
KR980009283A (ko) 1998-04-30
NZ328402A (en) 1999-03-29
HRP970384A2 (en) 1998-04-30
BR9704068A (pt) 1999-01-05
US20020103334A1 (en) 2002-08-01
PE92298A1 (es) 1999-02-13
MA24279A1 (fr) 1998-04-01
EE9700177A (et) 1998-02-16
AU5178701A (en) 2001-09-06
NO973426L (no) 1998-01-26
US6482798B2 (en) 2002-11-19
ATE260975T1 (de) 2004-03-15
HU9701290D0 (en) 1997-09-29
SG71714A1 (en) 2000-04-18
EP0821007B1 (de) 2004-03-03
HN1997000094A (es) 1997-12-26
ZA976585B (en) 1998-02-03
TNSN97130A1 (fr) 2005-03-15
CZ236797A3 (cs) 1998-02-18
UA55380C2 (uk) 2003-04-15
DZ2276A1 (fr) 2002-12-18
EP0821007A3 (de) 1998-11-18
CN1172116A (zh) 1998-02-04

Similar Documents

Publication Publication Date Title
MXPA02004666A (es) Gelatinas recombinantes.
BG102781A (en) Isolated dimer fibroblastactivation protein alpha and its application
ZA9710098B (en) Halogenopyrimidines.
WO1996017072A3 (en) Recombinant alphavirus vectors
DE69534778D1 (en) Cathepsin-02-protease
BG104943A (en) Biodegradable sustained-release alginate gels
BG103914A (en) Maintained separation of delayed gels
IL135648A0 (en) Novel 3, 6-hemiketals from the class of 9a-azalides
BG101787A (en) Aprotinine options having improved properties
EP0919576A4 (en) NEW COPOLYMER, METHOD FOR PRODUCING IT AND ITS USE
ZA974084B (en) Novel α-glucuronidases, production hereof and their uses.
IL139604A0 (en) Novel peptides
IL128500A0 (en) Substituted 1,2,3,4-tetrahydro-2-dibenzofuranamines and 2-aminocyclohepta (b) benzofurans
BG104707A (en) Caspase-8 interacting proteins
DE69737457D1 (de) O-fukosyltransferase
MX9700823A (es) Mezclas de poliisocianatos de baja viscosidad.
ZA987660B (en) Novel tissue-specific calpains, their preparation and use.
BG104373A (en) Polymorphous forms of dofetilide
GB2325466A (en) Nucleotide sequence from goat liver
ZA977491B (en) Use of polyhydroxycarboxylamides as EP additives.
BG102937A (en) Zona pelucida proteins as contraceptives
ZA9610510B (en) Novel peptides, the preparation and use thereof.
ZA978233B (en) The use of protein as anti-retroviral agents.
MX9702231A (es) Nuevos trimeros de isocianato y mezclas de trimeros de isocianato, su obtencion y empleo.
ZA975061B (en) Manufacture of articles.